Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line

Experimental Cell Research

Volumn 271, Issue 2, 2001, Pages 214-222

  Yasuoka, Yasuo ^a   Naomoto, Yoshio ^a   Yamatsuji, Tomoki ^a   Takaoka, Munenori ^a   Kimura, Masashi ^a   Uetsuka, Hirokazu ^a   Matsubara, Nagahide ^a   Fujiwara, Toshiyoshi ^a   Gunduz, Mehmet ^a   Tanaka, Noriaki ^a   Haisa, Minoru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Antisense oligonucleotides; Apoptosis; p53; TNF IFN

Indexed keywords

ALPHA INTERFERON; ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; MUTANT PROTEIN; MYC PROTEIN; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GENE MUTATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LUNG NON SMALL CELL CANCER; NUCLEOTIDE METABOLISM; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 0035842332     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5383     Document Type: Article

References (40)

1. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level
2. Human tumor necrosis factor produced by human B-cell lines: Synergistic cytotoxic interaction with human interferon
3. Mechanism of the combined antitumor effect of natural human tumor necrosis factor-alpha and natural human interferon-alpha on cell cycle progression
4. Synergism between human tumor necrosis factor-α and human interferon-α: Effects on cells in culture
5. In vitro synergistic effects of natural human tumor necrosis factor and natural human interferon-alpha
6. Synergistic effect of tumor necrosis factor-α and interferon-α on the induction of apoptosis detected by BM-1/JIBRO: A new marker of apoptosis
7. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
8. p53: Oncogene or antioncogene?
9. Tumor suppressor genes: The p53 and retinoblastoma sensitivity genes and gene products
10. The p53 tumour suppressor gene
11. Mice deficient for p53 are developmentally expressed normal but susceptible to spontaneous tumors
12. Hereditary p53 mutation in a patient with multiple tumors: Significance for genetic counseling
13. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding basal transcription factors to TATA motif
14. Control of c-myc regulation in normal and neoplastic cells
15. c-myc transactivates the p53 promoter through a required down-stream CACGTG motif
16. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA
17. Y antigen expression is correlated with apoptosis; programmed cell death
18. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
19. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
20. Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with an altered half life
21. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
22. Thymocyte apoptosis induced by p53-dependent and independent pathways
23. Mutant p53 antagonize the deregulated c-myc mediated enhancement of apoptosis and decrease in leukemogenicity
24. Association between cisplatin resistance and mutation of p53 gene and reduced BAX expression in ovarian carcinoma cell systems
25. Assignment of DNA binding sites for 4′,6-diamidine-2-phenilidole and bisbenzamide (Hoechst 33258). A comparative footprinting study
26. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells
27. c-myc induces cellular susceptibility to the cytotoxic action of TNF-alpha
28. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from GO to G1
29. Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes
30. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas
31. Induction of apoptosis in fibroblasts by c-myc protein
32. Mediation of c-myc-induced apoptosis by P53
33. Myc-mediated apoptosis required wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1
34. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis
35. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms
36. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
37. The TNF receptor-1-associated protein TRADD signals cell death and NF-κB activation
38. The involvement of the NF-κB in α-interferon gene regulation reveals its role as widely inducible mediator of signal transduction
39. Synergistic activation of NF-κB by tumor necrosis factor alpha and gamma interferon via enhanced I κB alpha degradation and de novo IκB beta degradation
40. Involvement of double-stranded RNA-activated protein kinase in the synergistic activation of nuclear factor-κB by tumor necrosis factor-alpha and gamma-interferon in preneuronal cells